We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vivoryon Therapeutics Nv | LSE:0R3M | London | Ordinary Share | NL00150002Q7 | VIVORYON THERAPEUTICS NV ORD SHRS |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 4.71 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
2,058 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | -3.62M | -28.34M | - | N/A | 0 |
Date | Time | Source | Headline |
---|---|---|---|
09/12/2024 | 06:00 | UKREG | Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND.. |
04/12/2024 | 06:00 | UKREG | Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and.. |
26/10/2024 | 07:30 | UKREG | Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of.. |
11/10/2024 | 13:20 | UKREG | Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the.. |
01/10/2024 | 05:00 | UKREG | Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease.. |
12/9/2024 | 05:00 | UKREG | Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling.. |
05/9/2024 | 16:12 | UKREG | Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction.. |
05/9/2024 | 05:00 | UKREG | Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on.. |
18/7/2024 | 05:00 | UKREG | Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment.. |
09/7/2024 | 05:00 | UKREG | Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused.. |
1 Year Vivoryon Therapeutics Nv Chart |
Intraday Vivoryon Therapeutics Nv Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions